Quality measurement is here to stay, but a JAMA viewpoint asks if anyone is keeping tabs on the costs of measurement.
In less than 20 years, the need to measure healthcare quality has become obvious. An infrastructure has grown up around the task of creating and validating measures, and deciding which ones CMS or commercial payers will use to connect pay with performance.
Measurement is here to stay, with CMS looking to tie 50% of all payments to value-based care by 2018 and physicians facing new requirements from the Medicare Access and CHIP Reauthorization Act.
But, as 3 authors in JAMA asked last week, is anyone keeping tabs on what measurement costs?
Mark A. Schuster, MD, PhD, and Sarah E. Onorato, BA, both of Boston Children’s Hospital and Harvard Medical School, and David O. Meltzer, MD, PhD, of the University of Chicago, took on this question in their essay, “Measuring the Cost of Quality Measurement: A Missing Link in Quality Strategy,” which observes that when selecting measures, cost is typically not a consideration. And that’s a problem, because the costs—especially data collection—can be considerable and the process time-consuming.
Then, the authors say, there’s the question of who pays. Are costs folded into hospital charges, insurance premiums, or other fees? Will the promise of electronic health records to bring down the cost of extracting data ever live up to the hype?
It’s time to be honest about the cost of measuring quality, the authors say. Bringing transparency and comparing the cost and value of similar measures would let the less useful (and less used) ones be discarded. An expensive measure that has high clinical value could be kept if its value can be demonstrated.
Cost should not be the only factor, they argue. But it has to be part of the equation, because doing so could inspire innovations to bring down the cost of the reporting process. That could also make things less burdensome for doctors and nurses if measurement fits better into the workflow.
The authors are not against measurement. “Measuring quality of care is essential to improving it,” they write. “However, the current, cost-uninformed approach has created a proliferation of measures, many of which are needlessly burdensome for health care organizations.”
If the point of measurement is to reveal what in healthcare has value, they authors say, the measures themselves have to pass muster.
Reference
Schuster MA, Onorato SE, Meltzer DO. Measuring the cost of quality measurement: a missing link in quality strategy [published August 31, 2017]. JAMA. 2017; doi:10.1001/jama.2017.11525
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More